IL-10 therapy has been proven to be clinically effective in the treatment of psoriasis by improving keratinocyte-associated pathologic parameters (50), and in the treatment of psoriatic arthritis by affecting endothelial activation, leukocyte recruitment, and effector function (51). This evidence concerns the gene IL10 and psoriasis.